Skip to content

Efficacy Observation of Repetitive Transcranial Magnetic Stimulation Combined with Gabapentin in the Treatment of Post-Stroke Central Pain

Efficacy Observation of Repetitive Transcranial Magnetic Stimulation Combined with Gabapentin in the Treatment of Post-Stroke Central Pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117689
Enrollment
Unknown
Registered
2026-01-27
Start date
2026-01-27
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Post-Stroke Neuropathic Pain ,CPSP

Interventions

Combined Treatment Group:10Hz rTMS Stimulation + Gabapentin + Conventional Rehabilitation Therapy
Gabapentin Group:Gabapentin + Conventional Rehabilitation Therapy
rTMS Group:10Hz rTMS Stimulation + Conventional Rehabilitation Therapy

Sponsors

Xuzhou Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients confirmed by cranial CT or MRI examination to have cerebral hemorrhage or cerebral infarction, meeting the diagnostic criteria for stroke established by the Chinese Medical Association; 2.The disease course ranges from 1 to 6 months, with stable vital signs and the ability to cooperate with physical examinations and treatment; 3.Neuropathic pain occurring after stroke, corresponding to the site of the stroke; 4.No history of rTMS or gabapentin treatment; 5.Signed informed consent form obtained; 6.Approved by the Ethics Committee of Xuzhou Rehabilitation Hospital.

Exclusion criteria

Exclusion criteria: 1.Patients with unstable conditions; 2.Central pain caused by other diseases (such as brain tumors, traumatic brain injury, multiple sclerosis, etc.); 3.Combined peripheral neuropathy; 4.Pregnant or lactating women; 5.Severe cognitive or speech impairment; 6.Presence of metal foreign objects in the skull.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale,VAS;

Secondary

MeasureTime frame
Hamilton depression scale,HAMD;Hamilton Anxiety Scale ,HAMA;Adverse Event Incidence Rate;Self- Rating Scale of Sleep,SRSS;leeds assessment of neuropathic symptoms and sign, LANSS;

Countries

China

Contacts

Public ContactBi Yingli

Xuzhou Rehabilitation Hospital

biyilang@163.com+86 18112000311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026